 Print previewpersonal data approved: 2023. I. 10. | Publications |
2022
 from data base, 2023. I. 10. |
Lohinai Zoltan, Dora David, Caldwell Charles, Rivard Christopher J., Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, Dziadziuszko Rafal, Mitchell Paul, John Thomas, Millan Inigo S., Ren Shengxiang, Hirsch Fred R.: Loss of STING expression is prognostic in non–small cell lung cancer, JOURNAL OF SURGICAL ONCOLOGY 125: (6) pp. 1042-1052.
type of document: Journal paper/Article
number of independent citations: 3
language: English
URL |
2022
from data base, 2023. I. 10. |
Dora David, Dora Timea, Szegvari Gabor, Gerdán Csongor, Lohinai Zoltan: EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers, BIODATA MINING 15: (1) 25
type of document: Journal paper/Article
language: English
URL |
2021
from data base, 2023. I. 10. |
Ni Yueqiong, Lohinai Zoltan, Heshiki Yoshitaro, Dome Balazs, Moldvay Judit, Dulka Edit, Galffy Gabriella, Berta Judit, Weiss Glen J., Sommer Morten O. A., Panagiotou Gianni: Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients, ISME JOURNAL 15: (11) pp. 3207-3220.
type of document: Journal paper/Article
number of independent citations: 16
language: English
URL |
2021
from data base, 2023. I. 10. |
Marfil-Sánchez Andrea, Seelbinder Bastian, Ni Yueqiong, Varga Janos, Berta Judit, Hollosi Virag, Dome Balazs, Megyesfalvi Zsolt, Dulka Edit, Galffy Gabriella, Weiss Glen J, Panagiotou Gianni, Lohinai Zoltan: Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients, PLOS ONE 16: (11) e0259898
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2020
from data base, 2023. I. 10. |
David Dora, Rivard Christopher, Yu Hui, Bunn Paul, Suda Kenichi, Ren Shengxiang, Pickard Shivaun Lueke, Laszlo Viktoria, Harko Tunde, Megyesfalvi Zsolt, Moldvay Judit, Hirsch Fred R, Dome Balazs, Lohinai Zoltan: Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution, MOLECULAR ONCOLOGY 14: (9) pp. 1947-1965.
type of document: Journal paper/Article
number of independent citations: 28
language: English
URL |
2019
from data base, 2023. I. 10. |
Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros Gy, Megyesfalvi Zs, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, Klepetko W, Laszlo V, Dome B: KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy, CANCERS 11: (10) 1514
type of document: Journal paper/Article
number of independent citations: 13
language: English
URL |
2019
from data base, 2023. I. 10. |
Lohinai Zoltan, Megyesfalvi Zsolt, Suda Kenichi, Harko Tunde, Ren Shengxiang, Moldvay Judit, Laszlo Viktoria, Rivard Christopher, Dome Balazs, Hirsch Fred R: Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases, TRANSLATIONAL LUNG CANCER RESEARCH 8: (6) pp. 938-950.
type of document: Journal paper/Article
number of independent citations: 3
language: English
URL |
2017
from data base, 2023. I. 10. |
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Tímár J, Fábián K, Kovalszky I, Kenessey I, Aigner C, Rényi-Vámos F, Klepetko W, Dome B, Hegedűs B: KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis, SCIENTIFIC REPORTS 7: 39721
type of document: Journal paper/Article
number of independent citations: 48
language: English
URL |
2015
from data base, 2023. I. 10. |
Lohinai Z, Hoda MA, Fabian K, Ostoros G, Raso E, Barbai T, Timar J, Kovalszky I, Cserepes M, Rozsas A, Laszlo V, Grusch M, Berger W, Klepetko W, Moldvay J, Dome B, Hegedus B: Distinct epidemiology and clinical consequence of classic versus rare EGFR mutations in lung adenocarcinoma., JOURNAL OF THORACIC ONCOLOGY 10: (5) pp. 738-746.
type of document: Journal paper/Article
number of independent citations: 56
language: English
URL |
2014
from data base, 2023. I. 10. |
Cserepes M, Ostoros G, Lohinai Z, Raso E, Barbai T, Timar J, Rozsas A, Moldvay J, Kovalszky I, Fabian K, Gyulai M, Ghanim B, Laszlo V, Klikovits T, Hoda MA, Grusch M, Berger W, Klepetko W, Hegedus B, Dome B: Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy, EUROPEAN JOURNAL OF CANCER 50: (10) pp. 1819-1828.
type of document: Journal paper/Article
number of independent citations: 57
language: English
URL |
| | Number of independent citations to these publications: | 225 |
|
|
Login
gmail.com
